by Eric Christianson | Jun 26, 2024 | Clinical Pharmacy News and New Drug Updates, Psychiatry and Addiction Medication and Disease State Clinical Pearls
I’ve encountered a significant proportion of patients who are on chronic benzodiazepines. Drug interactions, adverse effects, and other risks to my geriatric patient population are significant when using this class of medication. Benzodiazepine withdrawal is...
by Eric Christianson | Mar 27, 2024 | Neurology, Pain, and Musculoskeletal Medication and Disease State Clinical Pearls
For cancer patients, bone pain can be one of the most distressing symptoms to manage. Whether it’s due to metastasis, chemotherapy-induced effects, or other factors, finding effective pain relief is crucial for improving quality of life. In the realm of pain...
by Eric Christianson | Aug 23, 2023 | Neurology, Pain, and Musculoskeletal Medication and Disease State Clinical Pearls
Gabapentin is a frequently used medication for neuropathy, RLS, and various other pain syndromes. In this article, I discuss my top 5 reasons to avoid gabapentin use and pick an alternative. Sedation While the sedative nature of gabapentin can be beneficial when...
by Eric Christianson | Feb 15, 2023 | Personal Stories From The Front Lines of Clinical Pharmacy
This article was originally written by Christine Meyer, MD and I found this story too good not to share. I’m appreciative to her for letting me share it. Deprescribing and dose reductions require all hands on deck. Kudos to all of you pharmacists out there doing...
by Eric Christianson | Jan 1, 2023 | Neurology, Pain, and Musculoskeletal Medication and Disease State Clinical Pearls
Opioids are commonly used in clinical practice. Selection on these agents can often be confusion. We’ve outlined some of the most important pharmacokinetic, pharmacogenomic, and dosage form clinical pearls in the table below. For easier reading, we have also...
